School of Pharmacy Archives

Here’s how to make sense of the new guidance on booster shots. Photo by Ruby Wallau/Northeastern University

Why the Biden administration now says we need booster shots for COVID-19

New research reveals that COVID-19 vaccine protections began to decline in the middle of the summer when the delta variant was sweeping through the nation. “As we get new information, as the data provides new clues and a new direction in terms of what we need to do, we have to then respond accordingly,” says Neil Maniar, professor of public health practice at Northeastern.

by Eva Botkin-Kowacki August 18, 2021

This image shows SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2 is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Photo by: National Institute of Allergy and Infectious Diseases

How afraid of variants should we be?

The global death toll of the COVID-19 pandemic has surpassed 4 million, largely accelerated by dangerous variants of the coronavirus. Northeastern experts explain what you need to know about the risk of variants.

by Eva Botkin-Kowacki July 8, 2021

Adam Sternbach, right, embraces his 89 year-old mother Maryann Sternbach for the first time in over a year inside the Hebrew Home at Riverdale in New York. Because of the loosening of COVID-19 restrictions, it was the first time in over a year families of the nursing homes residents were allowed indoor, in-person visits. AP Photo/Kathy Willens

The COVID-19 pandemic exposed the vulnerability of people in nursing homes. But the real danger is loneliness.

Nursing homes across the U.S. tend to be located in socially isolated areas, according to new research by Northeastern scientists. And that can increase the risk of mortality for older adults.

by Eva Botkin-Kowacki June 17, 2021

Pedestrians, some with masks, some without walk along the Las Vegas Strip on April 27, 2021

What do the new CDC mask guidelines mean?

The U.S. Centers for Disease Control and Prevention has said that people fully vaccinated for the coronavirus no longer need to wear masks in public. How does that gibe with state and local rules mandating mask-wearing? And how will the new guidelines affect the vaccination rate? Northeastern faculty in law and public health unravel these questions.

by Eva Botkin-Kowacki May 14, 2021

Faculty Expert

Todd Brown

Vice Chair, Department of Pharmacy and Health Systems Sciences, School of Pharmacy

A cartoon by a student in professor Roger Giese’s biochemistry class, where students use drawings to convey advanced pharmacy topics. Courtesy of Roger Giese.

Confused about how the gene-editing tool CRISPR works? Try drawing it.

Student doodles gave professor Roger Giese an idea: Would cartoons help his students understand advanced topics in his biochemistry class?

by Kaitlyn Budion March 4, 2020

The 10th annual Bouvé Health Fair and Flu Clinic will offer a range of health services and information to Northeastern students, faculty, and staff. Photo by Matthew Modoono/Northeastern University

Free flu shots today at 10th annual Bouvé health fair

Today’s health fair and flu clinic in the Curry Student Center is the perfect opportunity to take stock of your health, with free flu shots, Zumba and yoga classes, health screenings, and wellness information available throughout the day.

by Molly Callahan October 5, 2016

09/08/15 - BOSTON, MA. - Diomedes Logothetis is a the new professor and chair, Department of Pharmaceutical Sciences. His research focuses on elucidating intracellular as well as cell-to-cell signaling mechanisms. Photo by: Matthew Modoono/Northeastern University

Advancing Northeastern’s leadership in drug discovery

Diomedes Logothetis, the new chair of the Department of Pharmaceutical Sciences, has a vision: To advance Northeastern’s standing as a go-to institution for academic researchers interested in drug discovery. “We can be the engine driving the understanding of how new drugs act,” he says.

by Thea Singer September 28, 2016

EpiPen’s pricing debacle and its impact on patients, insurers

A firestorm erupted this week in response to the pharmaceutical company Mylan’s sharp increase in the price of its EpiPen, a life-saving treatment for severe allergic reactions. The company quickly backtracked, announcing a rebate plan. Here, three Northeastern faculty members—pharmacist Tayla Rose, healthcare finance expert Steven Pizer, and health policy researcher Gary Young—explain the clinical, economic, and policy implications of the controversy.

by Thea Singer August 26, 2016